Study to evaluate the efficacy of Parikara Yoga (An Ayurvedic polyherbal formulation) and Dietary regimen in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedHealth Condition 2: K760- Fatty (change of) liver, not elsewhere classifiedHealth Condition 3: K77- Liver disorders in diseases classified elsewhere
- Registration Number
- CTRI/2023/08/055977
- Lead Sponsor
- ational Institute of Ayurveda Deemed to be University, Jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients of either sex of age group >18years and <60 years with USG
finding suggestive of fatty liver grade 1,2 and 3.
2.Non-Alcoholic or patients with history of alcohol addiction less than 20gm
per day in men and 10 gm per day in women.
3. Clinical sign and symptoms suggesting of Yakrita Roga/NAFLD that is,
pain in right upper quadrant/ epigastric region of abdomen, feeling of nausea,
heaviness in abdomen, flatulence ,loss of appetite and burning sensation in
abdomen if any.
4. Patients with normal serum bilirubin level and ALT/AST level less than 1.5
times of normal limit.
5. Patients with/without raised lipid profile.
1. Pregnant and lactating women.
2. Patients with history of diabetes mellitus, autoimmune hepatitis, drug
abuse, chronic Hepatitis, raised ALT/AST level more than 1.5 times of
normal limit.
3. Patients with complications of metabolic syndrome such as
cerebrovascular accident, myocardial infarction, chronic kidney diseases,
suffering from cirrhosis, ascites, variceal haemorrhage, coagulopathy,
hepatorenal syndrome
4. Patient have any kind of malignancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in USG findings and grading at the end of 56 daysTimepoint: Changes in USG findings and grading at the end of 56 days
- Secondary Outcome Measures
Name Time Method 1.Changes in liver function test, lipid profile at the and of 56 days <br/ ><br>2. Changes in clinical sign and symptoms if any at the end of 60 daysTimepoint: At the end of 56 days